BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36867360)

  • 1. Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.
    Peng P; Chen ZR; Zhang XL; Guo DS; Zhang B; He XM; Wan F
    Curr Med Sci; 2023 Feb; 43(1):156-165. PubMed ID: 36867360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
    Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
    Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma.
    Li W; Gao LN; Song PP; You CG
    Aging (Albany NY); 2020 Feb; 12(4):3558-3573. PubMed ID: 32087603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Prognostic Model of RNA-Binding Proteins in Colon Adenocarcinoma: A Study Based on TCGA and GEO Databases.
    Zhu D; Chen J; Hou T
    Cancer Manag Res; 2021; 13():7709-7722. PubMed ID: 34675667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a RNA Binding Protein-Associated Prognostic Model for Hepatocellular Carcinoma.
    Wang M; Jiang F; Wei K; Wang J; Zhou G; Wu C; Yin G
    Technol Cancer Res Treat; 2021; 20():15330338211004936. PubMed ID: 33910445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 6-RBP gene signature for a comprehensive analysis of glioma and ischemic stroke: Cognitive impairment and aging-related hypoxic stress.
    Lin W; Wang Q; Chen Y; Wang N; Ni Q; Qi C; Wang Q; Zhu Y
    Front Aging Neurosci; 2022; 14():951197. PubMed ID: 36118697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of an RNA-binding protein-associated prognostic model for colorectal cancer.
    Miao Y; Zhang H; Su B; Wang J; Quan W; Li Q; Mi D
    PeerJ; 2021; 9():e11219. PubMed ID: 33868829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Analysis of RNA-Binding Proteins in Glioma.
    Wang Z; Tang W; Yuan J; Qiang B; Han W; Peng X
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a prognostic model based on RNA binding proteins in patients with esophageal cancer.
    Du H; Li Y; Pang S; Enofe I; Pallante P; Zhu L; Hang J; Chen L
    J Thorac Dis; 2023 Nov; 15(11):6178-6191. PubMed ID: 38090289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas.
    Li X; Huang Z; Zhu L; Yu F; Feng M; Gu A; Jiang J; Wang G; Huang D
    Front Genet; 2022; 13():905751. PubMed ID: 35923699
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
    Sun R; Pan Y; Mu L; Ma Y; Shen H; Long Y
    Front Genet; 2021; 12():768930. PubMed ID: 34733320
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
    Wang X; Huang Y; Li S; Zhang H
    Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel microRNA-based signature for predicting the prognosis of glioma.
    Liu G; Rong X; Lin X; Wang H; He L; Peng Y
    Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669
    [No Abstract]   [Full Text] [Related]  

  • 18. The evaluation of six genes combined value in glioma diagnosis and prognosis.
    Lin P; He L; Tian N; Qi X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12413-12433. PubMed ID: 37439825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a five-lncRNA prognostic signature related to Glioma using bioinformatics analysis.
    Zhang C; Liu H; Xu P; Tan Y; Xu Y; Wang L; Liu B; Chen Q; Tian D
    BMC Cancer; 2021 Mar; 21(1):251. PubMed ID: 33750353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.